Clinicians can bill Category 1 CPT Code 75580 for adjunctive use of the artificial intelligence (AI)-powered Cleerly Ischemia software for fractional flow reserve estimates based on coronary computed tomography angiography (CCTA) scans.
A new Category 1 CPT code may enhance reimbursement for the use of adjunctive artificial intelligence (AI)-enabled software to ascertain fractional flow reserve (FFR) estimates in cases of suspected coronary artery disease (CAD).
The Cleerly Ischemia software (Cleerly), which can now be billed with the Category 1 CPT code 75580, allows non-invasive lesion mapping for findings of CAD, according to Cleerly, the develop of the Cleerly Ischemia software.
“The Cleerly Ischemia software provides noninvasive estimates of FFR values that help healthcare professionals make critical decisions in the management of patients with suspected coronary artery disease,” noted James P. Earls, M.D, the chief medical officer of Cleerly. “Cleerly Ischemia was purposely designed to output estimates of FFR values that are guideline-recommended by professional societies, and to allow comprehensive mapping of both anatomic and physiologic data for each and every coronary lesion across the entire vascular tree.”
Cleerly noted the new Category 1 CPT code is an addition to previously established Category III CPT codes for billing of the company’s advanced coronary atherosclerosis analysis.
Deep Learning Model with DCE-MRI May Help Predict Proliferative Hepatocellular Carcinoma
May 20th 2024Incorporating dynamic contrast-enhanced MRI, a deep learning model demonstrated a 20 percent higher AUC in external validation testing than clinical factors alone and over a 17 percent higher AUC than radiological factors alone in predicting proliferative hepatocellular carcinoma (HCC).
Multicenter CT Study Shows Benefits of Emerging Diagnostic Model for Clear Cell Renal Cell Carcinoma
May 15th 2024Combining clinical and CT features, adjunctive use of a classification and regression tree (CART) diagnostic model demonstrated AUCs for detecting clear cell renal cell carcinoma (ccRCC) that were 15 to 22 percent higher than unassisted radiologist assessments.
CT Study: AI Algorithm Comparable to Radiologists in Differentiating Small Renal Masses
May 14th 2024An emerging deep learning algorithm had a lower AUC and sensitivity than urological radiologists for differentiating between small renal masses on computed tomography (CT) scans but had a 21 percent higher sensitivity rate than non-urological radiologists, according to new research.